Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001628280-17-009028
Filing Date
2017-08-31
Accepted
2017-08-31 17:30:23
Documents
2
Effectiveness Date
2017-08-31

Document Format Files

Seq Description Document Type Size
1 DEFR14A schedule14aproxy2017.htm DEFR14A 454774
2 proxycardinfoa01.jpg GRAPHIC 5043
  Complete submission text file 0001628280-17-009028.txt   463195
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEFR14A | Act: 34 | File No.: 001-11504 | Film No.: 171064043
SIC: 2836 Biological Products, (No Diagnostic Substances)